Composition for activating fatty acid-G protein coupling acceptor route
A technology for coupling receptors and compositions, applied in the field of medicine, can solve problems such as limited drug effects, and achieve the effects of increasing abundance, maintaining host intestinal health, and reducing expression levels
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Example 1 (the polysaccharide in the composition is from the extract of Ganoderma lucidum, and the composition does not contain saponin)
[0054] A composition for activating fatty acid-G protein coupled receptor pathway, comprising polysaccharide; the polysaccharide is derived from the extract of medicinal material A, and the medicinal material A is Ganoderma lucidum.
[0055] In the composition, by weight percentage, the content of polysaccharide is 20%.
[0056] The content of the polysaccharide in the extract of medicinal material A is 50% by weight.
[0057] The extract of the medicinal material A also contains protein and alkaloids. The alkaloids are water-soluble alkaloids.
[0058] In the extract of the medicinal material A, by weight percentage, the protein content is 15%, and the alkaloid content is 1%.
[0059] The preparation process of the extract of the medicinal material A is as follows:
[0060] (1) Take medicinal material A, then pulverize, add 9 ti...
Embodiment 2
[0066] Embodiment 2 (the saponin in the composition comes from the extract of Gynostemma pentaphyllum, does not contain polysaccharide in the composition)
[0067] A composition for activating fatty acid-G protein-coupled receptor pathway, comprising saponin; the saponin is derived from the extract of medicinal material B, and the medicinal material B is Gynostemma pentaphyllum.
[0068] In the composition, by weight percentage, the content of saponin is 50%.
[0069] The content of said saponin in the extract of medicinal material B is 70% by weight.
[0070] In the extract of the medicinal material B, by weight percentage, the content of flavonoids is 3%, and the content of amino acids is 2%.
[0071] The preparation process of the extract of the medicinal material B is as follows:
[0072] (1) Take medicinal material B, then pulverize, add 10 times the weight of water or alcohol (that is, the quality of water or alcohol is 10 times the mass of medicinal material B), decoc...
Embodiment 3
[0080] A composition for activating fatty acid-G protein-coupled receptor pathway, comprising polysaccharide and saponin; the polysaccharide is derived from the extract of medicinal material A, and the medicinal material A is Ganoderma lucidum.
[0081] The saponin is derived from the extract of medicinal material B, which is Gynostemma pentaphyllum.
[0082] In the composition, by weight percentage, the content of polysaccharide is 30%, and the content of saponin is 40%.
[0083] The content of the polysaccharide in the extract of medicinal material A is 70% by weight.
[0084] In the extract of the medicinal material A, by weight percentage, the protein content is 15%, and the alkaloid content is 0.5%.
[0085] The content of said saponin in the extract of medicinal material B is 50% by weight.
[0086] In the extract of the medicinal material B, by weight percentage, the content of flavonoids is 4%, and the content of amino acids is 2%.
[0087] The preparation process o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com